Where do Protagonist Therapeutics's ratios come from?

Every ratio is computed from Protagonist Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	FY'25	FY'24	FY'23	FY'22
Profitability
Operating margin	-343.6%-402pp	58.2%—	——	-494.2%-34.2pp
Net margin	-282.8%-346pp	63.3%—	——	-479.3%-20.3pp
Returns
Return on equity	-20.2%-74.6pp	54.4%—	——	-49.4%-6.1pp
Return on invested capital	-29.1%-96.4pp	67.3%—	——	-95.3%-23.5pp
Efficiency
Asset turnover	0.1×-0.7×	0.8×+0.6×	0.2×+0.1×	0.1×0.0×
Liquidity
Current ratio	12.7×+0.2×	12.5×-4.2×	16.7×+8.9×	7.8×+0.1×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Per Share
Book value per share	$9.67-6.8%	$10.38+75.0%	$5.93+34.9%	$4.40-32.1%
Valuation
Market capitalization	$5.46B+137%	$2.3B+66.1%	$1.38B+158%	$536.75M-67.1%
Price / sales	118.7×+113×	5.3×-17.8×	23.1×+2.9×	20.2×-39.5×
Price / book	8.9×+5.5×	3.4×-0.7×	4.1×+1.6×	2.5×-3.0×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Protagonist Therapeutics.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Protagonist Therapeutics's ratios come from?: Every ratio is computed from Protagonist Therapeutics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.